Could AI Make Gene Editing Accessible to Millions? 🤯

Some genetic mutations affect as few as 10 people, making it difficult to develop a separate treatment for each one. But what if AI could help make that process faster and more scalable? Dr. Trevor Martin, CEO of Mammoth Biosciences, explains how AI-assisted drug design, manufacturing advances, and regulatory changes could help gene-editing therapies reach more patients, including those with ultra-rare genetic diseases. Watch the full episode! #AIInHealthcare #GeneEditing #CRISPR #GeneticMedicine #Biotech #MammothBiosciences #TheNeuron